Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Perfusion is a means to maintain a cell culture bioreactor in which equivalent volumes of media are simultaneously added and removed from the reactor while the cells are retained in the reactor.
Perfusion bioreactors offer several advantages over traditional fed-batch bioreactors when addressing problems of scalability and increasing demand.
Perfusion bioreactors culture cells over much longer periods, even months, by continuously feeding the cells with fresh media and removing spent media while keeping cells in culture. In perfusion there are different ways to keep the cells in culture while removing spent media.
Market Analysis and Insights: Global Perfusion Bioreactor Market
Due to the COVID-19 pandemic, the global Perfusion Bioreactor market size is estimated to be worth US$ 677 million in 2021 and is forecast to a readjusted size of US$ 677 million by 2028 with a CAGR of 9.3% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Perfusion Bioreactor global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Perfusion Bioreactor key players include Sartorius AG, Thermo Fisher, GE Healthcare Life Sciences, Pall, Eppendorf AG, etc. Global top five manufacturers hold a share over 50%.
North America is the largest market, with a share over 40%, followed by Asia-Pacific, and Europe, both have a share over 40 percent.
In terms of product, Mid-Scale (100Liters to 1,000 Liters) is the largest segment, with a share over 45%. And in terms of application, the largest application is Biopharmaceutical, followed by Biotechnology, etc.
Global Perfusion Bioreactor Scope and Market Size
The global Perfusion Bioreactor market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Perfusion Bioreactor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Small Scale (Less Than 100 Liters)
Mid-Scale (100 Liters to 1,000 Liters)
Large Scale (More Than 1,000 Liters)
Segment by Application
Biopharmaceutical
Biotechnology
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Sartorius AG
Thermo Fisher
GE Healthcare Life Sciences
Pall
Eppendorf AG
ZETA
3D Biotek
Infors HT
Applikon Biotechnology
Bioengineering AG
PBS Biotech, Inc.
Cell Culture Company
Zellwerk GmbH
Perfusion bioreactors offer several advantages over traditional fed-batch bioreactors when addressing problems of scalability and increasing demand.
Perfusion bioreactors culture cells over much longer periods, even months, by continuously feeding the cells with fresh media and removing spent media while keeping cells in culture. In perfusion there are different ways to keep the cells in culture while removing spent media.
Market Analysis and Insights: Global Perfusion Bioreactor Market
Due to the COVID-19 pandemic, the global Perfusion Bioreactor market size is estimated to be worth US$ 677 million in 2021 and is forecast to a readjusted size of US$ 677 million by 2028 with a CAGR of 9.3% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Perfusion Bioreactor global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
Global Perfusion Bioreactor key players include Sartorius AG, Thermo Fisher, GE Healthcare Life Sciences, Pall, Eppendorf AG, etc. Global top five manufacturers hold a share over 50%.
North America is the largest market, with a share over 40%, followed by Asia-Pacific, and Europe, both have a share over 40 percent.
In terms of product, Mid-Scale (100Liters to 1,000 Liters) is the largest segment, with a share over 45%. And in terms of application, the largest application is Biopharmaceutical, followed by Biotechnology, etc.
Global Perfusion Bioreactor Scope and Market Size
The global Perfusion Bioreactor market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Perfusion Bioreactor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Small Scale (Less Than 100 Liters)
Mid-Scale (100 Liters to 1,000 Liters)
Large Scale (More Than 1,000 Liters)
Segment by Application
Biopharmaceutical
Biotechnology
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Sartorius AG
Thermo Fisher
GE Healthcare Life Sciences
Pall
Eppendorf AG
ZETA
3D Biotek
Infors HT
Applikon Biotechnology
Bioengineering AG
PBS Biotech, Inc.
Cell Culture Company
Zellwerk GmbH
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
